DSAEK术后3年内皮细胞丢失的相关因素:供体、受体与手术因素分析
该研究为角膜保存时间研究(CPTS)的二次分析,纳入749例(913眼)DSAEK术后有功能移植片且内皮图像合格者,评估供体、受体及手术因素与3年内皮细胞密度(ECD)的关联。多变量模型显示供体糖尿病、较低筛查ECD、受体诊断为无晶状体/人工晶状体性角膜水肿(PACE)及术中并发症与3年ECD较低相关,其余因素无显著关联。
要点
- 供体糖尿病与3年ECD较低相关(估计效应-103 cells/mm2,99%CI -196至-9)。
- 受体诊断为PACE与3年ECD较低相关(估计效应-257 cells/mm2,99%CI -483至-31)。
- 术中并发症与3年ECD较低相关(估计效应-324 cells/mm2,99%CI -516至-133)。
核心结论
- 供体糖尿病、较低筛查ECD、受体PACE诊断及术中并发症与DSAEK术后3年ECD较低相关,可能关联长期移植片存活。
- 不能推断因果关系,供体糖尿病与受体PACE和3年ECD较低的关联值得进一步研究。
研究设计与样本
- 多中心、双盲、随机临床试验(CPTS)的队列二次分析,纳入美国40个临床中心70名术者及23家眼库供体角膜。
- 纳入Fuchs营养不良或人工晶状体/无晶状体性角膜水肿行DSAEK者,随机分配供体角膜保存时间0-7天或8-14天。
- 共1090例参与者(1330眼)中,749例(913眼)术前及术后3年内皮图像合格且有功能移植片者纳入本分析。
主要发现
- 3年ECD较低相关因素(估计效应,99%CI):供体糖尿病-103(-196至-9)cells/mm2,筛查ECD每低500 cells/mm2为-234(-331至-137)。
- 受体PACE诊断-257(-483至-31)cells/mm2,术中并发症-324(-516至-133)cells/mm2。
- 术前至术后3年内皮细胞丢失率:供体糖尿病者47%(99%CI 42%-52%) vs 无糖尿病者43%(99%CI 39%-48%)。
- PACE诊断者53%(99%CI 44%-62%) vs Fuchs营养不良者44%(99%CI 39%-49%)。
- 术中并发症者55%(99%CI 48%-63%) vs 无并发症者44%(99%CI 39%-48%)。
关键数值与推荐
- 3年ECD较低相关因素(估计效应,99%CI):供体糖尿病-103(-196至-9)cells/mm2,筛查ECD每低500 cells/mm2为-234(-331至-137)。
- 受体PACE诊断-257(-483至-31)cells/mm2,术中并发症-324(-516至-133)cells/mm2。
- 术前至术后3年内皮细胞丢失率:供体糖尿病者47%(99%CI 42%-52%) vs 无糖尿病者43%(99%CI 39%-48%)。
- PACE诊断者53%(99%CI 44%-62%) vs Fuchs营养不良者44%(99%CI 39%-49%)。
- 术中并发症者55%(99%CI 48%-63%) vs 无并发症者44%(99%CI 39%-48%)。
临床怎么用
- 对供体糖尿病、低筛查ECD、受体PACE诊断或术中并发症的DSAEK病例,应预期3年内皮细胞密度更低并加强随访。
- 术前可结合供体糖尿病史与筛查ECD评估移植片长期存活风险,术中尽量避免并发症。
局限性
- 本研究为二次分析,不能推断因果关系。
- 仅纳入术前及术后3年内皮图像合格且有功能移植片的患眼,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Determining factors associated with endothelial cell loss after Descemet stripping automated endothelial keratoplasty (DSAEK) could improve long-term graft survival. OBJECTIVE: To evaluate the associations of donor, recipient, and operative factors with endothelial cell density (ECD) 3 years after DSAEK in the Cornea Preservation Time Study. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a secondary analysis of data collected in a multicenter, double-masked, randomized clinical trial. Forty US clinical sites with 70 surgeons participated, with donor corneas provided by 23 US eye banks. Individuals undergoing DSAEK for Fuchs dystrophy or pseudophakic/aphakic corneal edema were included. INTERVENTIONS: The DSAEK procedure, with random assignment of a donor cornea with a preservation time of 0 to 7 days or 8 to 14 days. MAIN OUTCOMES AND MEASURES: Endothelial cell density at 3 years as determined by a reading center from eye bank and clinical specular or confocal central endothelial images. RESULTS: The study included 1090 participants (median age, 70 years) with 1330 affected eyes (240 bilateral cases [22.0%]), who underwent DSAEK for Fuchs dystrophy (1255 eyes [94.4%]) or pseudophakic/aphakic corneal edema (PACE) (75 eyes [5.6%]). Of these, 801 eyes (60.2%) belonged to women and 1207 (90.8%) to white individuals. A total of 749 participants (913 eyes; 164 [21.9%] bilateral cases) had functioning grafts with acceptable endothelial images preoperatively and at 3 years postoperatively and were included in this analysis. Factors associated with a lower ECD at 3 years (estimated effect with 99% CI) in the final multivariable model included donors with diabetes (-103 [-196 to -9] cells/mm2), lower screening ECD (-234 [-331 to -137] per 500 cells/mm2), recipient diagnosis of PACE (-257 [-483 to -31] in cells/mm2), and operative complications (-324 [-516 to -133] in cells/mm2). Endothelial cell loss (ECL) from a preoperative measurement to a 3-year postoperative measurement was 47% (99% CI, 42%-52%) for participants receiving tissue from donors with diabetes vs 43% (99% CI, 39%-48%) without diabetes; it was 53% (99% CI, 44%-62%) for participants diagnosed with PACE vs 44% (99% CI, 39%-49%) for those diagnosed with Fuchs dystrophy, and 55% (99% CI, 48%-63%) in participants who experienced operative complications vs 44% (99% CI, 39%-48%) in those who did not. No other donor, recipient, or operative factors were significantly associated with 3-year ECD. CONCLUSIONS AND RELEVANCE: Donor diabetes, lower screening ECD, a PACE diagnosis in the recipient, and operative complications were associated with lower ECD at 3 years after DSAEK surgery and may be associated with long-term graft success. While causation cannot be inferred, further studies on the association of donor diabetes and PACE in recipients with lower 3-year ECD warrant further study.
引用
- Lass JH, Benetz BA, Patel SV, et al. Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study. JAMA Ophthalmol. 2019. PMID: 30422157. doi:10.1001/jamaophthalmol.2018.5669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。